📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
GLAXOSMITHKLINE PHARMACEUTICALS LTD.GLAXOPharmaceuticals
Open
2476
High
2500.9
Low
2451.2
Close
2483.7
Volume
49110
Exchange
nse
Time
15-Jul-2026

Outlook

Score:  

4.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Glaxosmithkline Pharmaceuticals is  
Short Line
Estimated Stoploss of Glaxosmithkline Pharmaceuticals is ₹  
2451.2
Glaxosmithkline Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Short Line
 candle pattern indicates the trend direction of Glaxosmithkline Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Glaxosmithkline Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glaxosmithkline Pharmaceuticals is  
Upℹ
 by  

6.05

%. 
Target
Buy @ 

2149.35

Sell @ 

2561.05

Current @ 

2483.7

Volume

The trade volumes of Glaxosmithkline Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Glaxosmithkline Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Glaxosmithkline Pharmaceuticals is  

Down

 by  

51.52

% 

Valuation

The current market price of Glaxosmithkline Pharmaceuticals is  
Fairℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 4108cr and total assets worth ₹ 4108cr, the balance sheet of Glaxosmithkline Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glaxosmithkline Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 474cr

. It is  
Upℹ
 by  

1534.48

%. 

(*Mar 2025)

61.29% i.e. ₹ 1289cr earned in operatingℹ
2.14% i.e. ₹ 45cr spent in investingℹ
36.57% i.e. ₹ 769cr spent in financingℹ
0% in otherℹ
Glaxosmithkline Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 29cr

. It is  
Upℹ
 by  

111.55

%. 

(*Mar 2024)

50.56% i.e. ₹ 582cr earned in operatingℹ
0.7% i.e. ₹ 8cr earned in investingℹ
48.74% i.e. ₹ 561cr spent in financingℹ
0% in otherℹ
Income
The income of Glaxosmithkline Pharmaceuticals is  

₹ 1013cr

 and  

Profit

 is :  

₹ 257cr

(*Sep 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

25.37

% and Income is Up by:  

19.46

% 

(*Sep 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 848cr

 and  

Profit

 is :  

₹ 205cr

(*Jun 2025)

Glaxosmithkline Pharmaceuticals Profit is down by:  

21.76

% and Income is Down by:  

16.45

% 

(*Jun 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 1015cr

 and  

Profit

 is :  

₹ 262cr

(*Mar 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

14.41

% and Income is Up by:  

3.15

% 

(*Mar 2025)

Market Cap

Market capital of GlaxoSmithkline Pharmaceuticals Ltd. is 42324cr

Top Rated Competitors

NameScore
RPG Life Sciences Limited
6
BDH Industries Ltd.
6
KIMIA BIOSCIENCES LIMITED
5.75
Marksans Pharma Ltd.
5.75
Pfizer Ltd.
5.5
Abbott India Ltd.
5.5
Kilitch Drugs (I) Ltd.
5.5
Lactose (India) Ltd.
5.25
Fredun Pharmaceuticals Limited
5.25
Lupin Ltd
5.25
By using this site you agree to the use of cookies to deliver a better site experience.